NFSG
PALI icon

Newbridge Financial Services Group’s Palisade Bio PALI Stock Holding History

Newbridge Financial Services Group’s Portfolio PALI Stock Details PALI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.8K Buy
17,000
+2,000
+13% +$3.64K ﹤0.01% 554
2025
Q4 		$35.3K Buy
15,000
+2,000
+15% +$3.84K 0.01% 509
2025
Q3 		$11.2K Buy
13,000
+2,500
+24% +$1.95K ﹤0.01% 873
2025
Q2 		$7.14K Buy
+10,500
New +$7.52K ﹤0.01% 960

Other funds holding PALI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Newbridge Financial Services Group's PALI Position: Q1 2026 in Review

Newbridge Financial Services Group increased its Palisade Bio (PALI) stake by 13% in Q1 2026, buying an estimated $3.64K and bringing the position to 17,000 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #554.

Newbridge Financial Services Group first reported a position in PALI in Q2 2025 and has held it in 4 quarters since. The position peaked at $35.3K in Q4 2025. 96 funds tracked by Wall St. Rank hold PALI as of Q1 2026.

  • Newbridge Financial Services Group held 17,000 shares of Palisade Bio worth $29.8K as of Q1 2026.
  • Newbridge Financial Services Group bought 2,000 Palisade Bio shares in Q1 2026, an estimated $3.64K.
  • Palisade Bio made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #554 holding.
  • Newbridge Financial Services Group first reported a position in Palisade Bio in Q2 2025 and has held it in 4 quarters since.
  • Newbridge Financial Services Group's Palisade Bio position peaked at $35.3K in Q4 2025.
  • 96 funds tracked by Wall St. Rank held Palisade Bio as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.